Hot Reads: Value A Better Vaccine Bet

September 21, 2020

Compiled by ETF.com Staff

 

Value, Not Cyclicals, Would Rally Most on Vaccine (Bloomberg)
Value shares are a better way to bet on a COVID-19 vaccine than cyclical stocks, according to Goldman Sachs.

 

Where Performance Fees Don't Work (Institutional Investor)
The case against performance fees for factor-based strategies.

 

ARK Fund Buys More Tesla After Shares Got "Slapped" (Bloomberg)
Tesla is top holding in 'ARKK.'
 

Companies Rushing To IPO Before The Election (CNN Money)
The Fed’s decision to keep interest rates at zero for the foreseeable future has helped fuel demand for IPOs.

 

Sustainable Fund Performance Beats Peers (Investment News)
Despite the pandemic, ESG flows are breaking records this year.

 

Taking Stock Of A Drawdown That Hasn't Stuck (Parametric Portfolios)
Global markets have proven resilient, but investors are still wary.

 

Aging & Equities (CFA Institute)
As the population ages, who will be left to buy stocks?

 

Negativity Is Not An Investment Strategy (A Wealth Of Common Sense)
Any position you take in regard to your portfolio involves risk. 

 

Money Market Funds Undergoing Shift (Disciplined Global Systematic Macro Views) 
The money market asset management business is again going through an existential threat from the Fed.

Find your next ETF

Reset All